Senate FDA reform bill to include national uniformity language; markup planned for June 4.
This article was originally published in The Rose Sheet
Executive Summary
NATIONAL UNIFORMITY PROVISION UNDER DEVELOPMENT FOR SENATE FDA REFORM legislation, according to a Labor & Human Re-sources Committee summary of the FDA reform bill. At a press briefing May 28, the committee noted that national uniformity language allowing FDA regulations to supersede state and local safety and labeling laws for cosmetics and over-the-counter drugs would be expanded beyond what was included in last year's Senate FDA reform bill.